Lobular Breast Cancer Alliance advocate and patient Diane Mapes tells her story of being diagnosed with sneaky lobular breast cancer and why we need more research to better understand this disease. Reprinted with permission from Healthline, Inc.
We are sad to announce that the 2nd ILC Symposium organizing committee – including the Lobular Breast Cancer Alliance advocates – have canceled the 2nd
2nd ILC Symposium and Lobular Advocate Boot Camp Canceled Read More »
LBCA partnered with Living Beyond Breast Cancer (LBBC) to present Medical Update: Metastatic Lobular Breast Cancer at LBBC’s Virtual Conference on Metastatic Breast Cancer June
Medical Update: Metastatic Lobular Breast Cancer Read More »
May, 2020 by Priscilla F. McAuliffe MD PhD, Beth Z. Clark MD, Jennifer M. Xavier PhD, Steffi Oesterreich PhD, Rachel C. Jankowitz MD The unprecedented
Cancer Research Clinical Trials During the COVID-19 Pandemic Read More »
The Lobular Breast Cancer Alliance presented a research poster at the San Antonio Breast Cancer Symposium (SABCS) December 11, 2019 sharing the findings of a
LBCA Presents Survey Results at SABCS 2019 Read More »
Know where ILC can spread and the symptoms of metastasis
Metastatic Sites and Symptoms of ILC Read More »
Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a multi-site clinical trial. This clinical trial will compare how lobular breast tumors respond to three different commonly prescribed, effective medications that are currently being used to treat breast cancer.Â
Clinical Trial: Endocrine Response in Pre-Surgical ILC Patients Read More »
Susan G. Komen partnered with the Lobular Breast Cancer Alliance to host a webinar Lobular Breast Cancer: A Different Disease. This webinar is geared towards
Research Advocate Education: Lobular Breast Cancer- A Different Disease Read More »
Patients with Metastatic Lobular Breast Cancer (cancer has spread beyond the breast to other parts of the body) have a unique opportunity to advance critical research by participating in the Metastatic Breast Cancer Project’s ILC initiative.
Patients with ILC Mets Needed to Advance Research Read More »
The Lobular Breast Cancer Alliance sent several research advocates to participate in the 2019 San Antonio Breast Cancer Symposium. LBCA advocates submitted an abstract and
Lobular Research at the San Antonio Breast Cancer Symposium 2019 Read More »
The 2019 Northwest Metastatic Breast Cancer conference was held in Seattle, WA on September 7th, 2019. It featured a Lobular Lunch and Learn presentation by
NW Metastatic Breast Cancer Conference 2019 Read More »
The European Lobular Breast Cancer Consortium (ELBCC) seeks to increase collaboration and advance research into therapies for patients with lobular breast cancer (ILC).
ILC Research Consortium Forms in Europe, Includes Advocates Read More »
Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.
© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices
Site by SuzanneHarrisonWeb.com